Fintel reports that on February 28, 2025, Goldman Sachs initiated coverage of Summit Therapeutics (NasdaqGM:SMMT) with a Buy ...

Pharmaceutical company Summit Therapeutics is standing out today, surging to $20.45 and marking a 10.6% change. In comparison ...

U.S. stocks staged a comeback on Friday, with the S&P 500 surging 1.59% and reversing a sharp sell-off driven by fears that ...

With the UK buying nearly 100,000 Chinese cars in 2024, a motoring expert has shared how the country has become the world's ...

Piper Sandler analyst Yasmeen Rahimi initiated coverage on Avalo Therapeutics, Inc. AVTX with an Overweight rating and ...